INVO Bioscience, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by INVO Bioscience, Inc. (trading symbol: INVO) on November 29, 2021. The company is incorporated in Nevada and its principal executive offices are located in Sarasota, Florida. The report details a material definitive agreement entered into on the date of the report.
Key Financial Metrics
This filing does not contain comprehensive financial statements, revenue, profit, cash flow, or margin data. The only financial figures disclosed relate to a specific equity transaction:
- Transaction Type: Amendment to Stock Purchase Agreement with Paradigm Opportunities Fund, LP.
- Shares Involved: 600,703 shares of common stock.
- Purchase Price: $3.329 per share.
- Aggregate Purchase Price: $1,999,740.29.
- Revised Closing Date: Extended to December 31, 2021 (originally November 30, 2021).
Material Changes
The primary material change reported is the extension of the closing date for the sale of common stock to Paradigm Opportunities Fund, LP. The original agreement, dated October 1, 2021, required closing on November 30, 2021. The amendment executed on November 29, 2021, extended this deadline to December 31, 2021.
Guidance, Outlook, and Risks
The filing does not provide forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard legal disclaimer that the summary is qualified by the full text of the Amendment (Exhibit 10.1). No unusual items or contingencies were disclosed in the text of this report.
Investor Verification Checklist
- Verify the execution of the Amendment to Stock Purchase Agreement (Exhibit 10.1) to confirm the final terms of the share sale.
- Confirm the actual closing of the transaction by December 31, 2021, as the extended deadline.
- Review subsequent filings to determine if the $1,999,740.29 in proceeds were received and how they were utilized.
- Check for any further amendments or delays regarding the closing date if the transaction has not yet been completed.